Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lalit K Golani

Showing results (1-10 of 26) with videos related to

Pageof 3
Sort By:
International Journal of Developmental Neuroscience : the Official Journal of the International Society for Developmental Neuroscience|November 11, 2020
Papaverine ameliorates prenatal alcohol-induced experimental attention deficit hyperactivity disorder by regulating neuronal function, inflammation, and oxidative stressNiti Sharma, Neerupma Dhiman, Lalit K Golani, et al.
Expert Review of Clinical Pharmacology|March 31, 2023
Clinical pharmacological innovation in the treatment of depressionJeffrey M Witkin, Lalit K Golani, Jodi L Smith
Alcohol (Fayetteville, N.Y.)|August 22, 2022
Vinpocetine, a PDE1 modulator, regulates markers of cerebral health, inflammation, and oxidative stress in a rat model of prenatal alcohol-induced experimental attention deficit hyperactivity disorderNiti Sharma, Kanishk Luhach, Lalit K Golani, et al.
Behavioural Pharmacology|December 8, 2020
Blockade of α1 subtype GABAA receptors attenuates the development of tolerance to the antinociceptive effects of midazolam in ratsLakeisha A Lewter, Lalit K Golani, James M Cook, et al.
Synthesis|August 11, 2020
Improved Synthesis of Anxiolytic, Anticonvulsant and Antinociceptive α2/α3-GABA(A)ergic Receptor Subtype Selective Ligands as Promising Agents to Treat Anxiety, Epilepsy, as well as Neuropathic PainGuanguan Li, Lalit K Golani, Rajwana Jahan, et al.
Behavioural Pharmacology|January 15, 2019
Effects of the α2/α3-subtype-selective GABAA receptor positive allosteric modulator KRM-II-81 on pain-depressed behavior in rats: comparison with ketorolac and diazepamMegan J Moerke, Guanguan Li, Lalit K Golani, et al.
Advances in Pharmacology (San Diego, Calif.)|July 4, 2020
Involvement of muscarinic receptor mechanisms in antidepressant drug actionJeffrey M Witkin, Jodi L Smith, Lalit K Golani, et al.
Advances in Pharmacology (San Diego, Calif.)|August 6, 2019
Rapid-acting antidepressantsJeffrey M Witkin, Anna E Martin, Lalit K Golani, et al.
Bioorganic & Medicinal Chemistry|June 7, 2020
Design, synthesis and biological evaluation of novel pyrrolo[2,3-d]pyrimidine as tumor-targeting agents with selectivity for tumor uptake by high affinity folate receptors over the reduced folate carrierLalit K Golani, Farhana Islam, Carrie O'Connor, et al.
International Journal of Molecular Sciences|June 27, 2024
(<i>R</i>)-(-)-Ketamine: The Promise of a Novel Treatment for Psychiatric and Neurological DisordersHana Shafique, Julie C Demers, Julia Biesiada, et al.
Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
International Journal of Developmental Neuroscience : the Official Journal of the International Society for Developmental Neuroscience|November 11, 2020
Papaverine ameliorates prenatal alcohol-induced experimental attention deficit hyperactivity disorder by regulating neuronal function, inflammation, and oxidative stressNiti Sharma, Neerupma Dhiman, Lalit K Golani, et al.
Expert Review of Clinical Pharmacology|March 31, 2023
Clinical pharmacological innovation in the treatment of depressionJeffrey M Witkin, Lalit K Golani, Jodi L Smith
Alcohol (Fayetteville, N.Y.)|August 22, 2022
Vinpocetine, a PDE1 modulator, regulates markers of cerebral health, inflammation, and oxidative stress in a rat model of prenatal alcohol-induced experimental attention deficit hyperactivity disorderNiti Sharma, Kanishk Luhach, Lalit K Golani, et al.
Behavioural Pharmacology|December 8, 2020
Blockade of α1 subtype GABAA receptors attenuates the development of tolerance to the antinociceptive effects of midazolam in ratsLakeisha A Lewter, Lalit K Golani, James M Cook, et al.
Synthesis|August 11, 2020
Improved Synthesis of Anxiolytic, Anticonvulsant and Antinociceptive α2/α3-GABA(A)ergic Receptor Subtype Selective Ligands as Promising Agents to Treat Anxiety, Epilepsy, as well as Neuropathic PainGuanguan Li, Lalit K Golani, Rajwana Jahan, et al.
Behavioural Pharmacology|January 15, 2019
Effects of the α2/α3-subtype-selective GABAA receptor positive allosteric modulator KRM-II-81 on pain-depressed behavior in rats: comparison with ketorolac and diazepamMegan J Moerke, Guanguan Li, Lalit K Golani, et al.
Advances in Pharmacology (San Diego, Calif.)|July 4, 2020
Involvement of muscarinic receptor mechanisms in antidepressant drug actionJeffrey M Witkin, Jodi L Smith, Lalit K Golani, et al.
Advances in Pharmacology (San Diego, Calif.)|August 6, 2019
Rapid-acting antidepressantsJeffrey M Witkin, Anna E Martin, Lalit K Golani, et al.
Bioorganic & Medicinal Chemistry|June 7, 2020
Design, synthesis and biological evaluation of novel pyrrolo[2,3-d]pyrimidine as tumor-targeting agents with selectivity for tumor uptake by high affinity folate receptors over the reduced folate carrierLalit K Golani, Farhana Islam, Carrie O'Connor, et al.
International Journal of Molecular Sciences|June 27, 2024
(<i>R</i>)-(-)-Ketamine: The Promise of a Novel Treatment for Psychiatric and Neurological DisordersHana Shafique, Julie C Demers, Julia Biesiada, et al.
Pageof 3